Skip to content

To evaluate the effect of clove oil, betel leaf extract, lignocaine gels and ice for pain reduction during intraoral injections

Comparative Evaluation of pain perception following topical application of Clove Oil, Betel leaf extract, Lignocaine gels and Ice prior to intraoral injection in children aged 6-10years. - A Randomized Control Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029937
Enrollment
60
Registered
2020-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: Clove oil: Applied in the buccal vestibule in maxillary anterior region for 60 seconds prior to intraoral injection Intervention2: 10% Betel Leaf extract: Applied in the buccal vestibul

Sponsors

Dr Kanchan M Tuppadmath
Lead Sponsor
Dr Raghavendra Havale
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: A) Children of age group of 6-10 years. B) Children requiring administration of infiltration anesthesia irrespective of treatment. C) Children with Franklâ??s behaviour rating 3 and 4. D) Children with good general health (ASA I). E) Children who are willing to participate and whose parents give informed consent.

Exclusion criteria

Exclusion criteria: A) Medically compromised children. B) Patient with history of anxiety disorder. C) Children or parents not willing to participate. D) Patients with history of allergy to local anesthesia. E) Patients on medication that can alter pain perception. F) Children with active pathology at the administration site.

Design outcomes

Primary

MeasureTime frame
To compare and evaluate the pain perception following topical application of clove oil, betel leaf extract, lignocaine gels & ice prior to intraoral infilterations.Timepoint: 60 seconds after the application of comparator agents

Secondary

MeasureTime frame
To evaluate for any adverse effects following topical application of comparator agentTimepoint: 60 seconds after the application of comparator agents

Countries

India

Contacts

Public ContactDr Dhanu G

Academy of Medical Education Raichur

raghavendrahavale@yahoo.co.in9448407300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026